Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes.

Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes.

Item
http://www.wikidata.org/entity/Q34853371
An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in ItalyAutophagy enhances bacterial clearance during P. aeruginosa lung infection.Molecular detection and antimicrobial resistance of Pseudomonas aeruginosa from houseflies (Musca domestica) in Iran.Does the piperacillin minimum inhibitory concentration for Pseudomonas aeruginosa influence clinical outcomes of children with pseudomonal bacteremia?Detection of SHV type Extended-Spectrum B-lactamase and Risk Factors in Pseudomonas aeruginosa Clinical Isolates.Fingerprint Analysis and Identification of Strains ST309 as a Potential High Risk Clone in a Pseudomonas aeruginosa Population Isolated from Children with Bacteremia in Mexico CityIdentification of a hidden outbreak due to the spread of a VIM-3-producing, extensive drug-resistant Pseudomonas aeruginosa (XDRPA) clone at a regional hospital in Taiwan.A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.Prevalence, clinical features, and outcome of pseudomonas bacteremia in under-five diarrheal children in bangladesh.Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012.Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.An empiric antibiotic protocol using risk stratification improves antibiotic selection and timing in critically ill children.An usual approach to treatment of a case of multidrug resistance Pseudomonas aeruginosa peritonitis: parenteral and intraperitoneal aminoglycosides and parenteral colistin.
P2860

Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes.

Item
http://www.wikidata.org/entity/Q34853371
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@ast
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@en
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@nl
type
label
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@ast
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@en
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@nl
prefLabel
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@ast
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@en
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Pseudomonas aeruginosa bactere ...... istance and clinical outcomes.
@en
P2093
P2860
P304
P31
P356
10.3346/JKMS.2011.26.5.612
P433
P478
P577
P5875
P698
P921
P932